ES2186166T3 - Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal. - Google Patents

Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal.

Info

Publication number
ES2186166T3
ES2186166T3 ES98924850T ES98924850T ES2186166T3 ES 2186166 T3 ES2186166 T3 ES 2186166T3 ES 98924850 T ES98924850 T ES 98924850T ES 98924850 T ES98924850 T ES 98924850T ES 2186166 T3 ES2186166 T3 ES 2186166T3
Authority
ES
Spain
Prior art keywords
peritoneal dialysis
natural peptide
anp
additive
dialysis solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98924850T
Other languages
English (en)
Inventor
Chi J Chen
Ty R Shockley
Miles G Johnston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2186166T3 publication Critical patent/ES2186166T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • External Artificial Organs (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA UNA SOLUCION PARA DIALISIS PERITONEAL QUE CONTIENE UN PEPTIDO NATRIURETICO ATRIAL (PNA), UN DERIVADO DEL PNA, UN ANALOGO DEL PNA, UNA SUBSTANCIA QUE FIJA EL PNA A RECEPTORES DEL ACLARAMIENTO, O UNA SUBSTANCIA QUE PROMUEVE LA SINTESIS DEL PNA, Y QUE DA COMO RESULTADO UN AUMENTO DE LA ULTRAFILTRACION NETA Y UN AUMENTO DEL ACLARAMIENTO DEL SODIO EXPERIMENTADO EN PACIENTES DE DIALISIS PERITONEAL.
ES98924850T 1997-05-23 1998-05-21 Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal. Expired - Lifetime ES2186166T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/862,480 US5965533A (en) 1997-05-23 1997-05-23 Atrial natriuretic peptide (ANP) as an additive to peritoneal dialysis solutions

Publications (1)

Publication Number Publication Date
ES2186166T3 true ES2186166T3 (es) 2003-05-01

Family

ID=25338600

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98924850T Expired - Lifetime ES2186166T3 (es) 1997-05-23 1998-05-21 Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal.

Country Status (12)

Country Link
US (1) US5965533A (es)
EP (1) EP0914147B1 (es)
JP (1) JP2000516836A (es)
KR (1) KR20000029447A (es)
CN (1) CN1226832A (es)
AU (1) AU733210B2 (es)
BR (1) BR9804921A (es)
CA (1) CA2261681A1 (es)
DE (1) DE69808717T2 (es)
ES (1) ES2186166T3 (es)
ID (1) ID21765A (es)
WO (1) WO1998052599A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69927093T2 (de) * 1998-07-07 2006-06-29 Terumo K.K. Lösung für die Peritonealdialyse
WO2000013698A1 (en) * 1998-09-04 2000-03-16 University Of Utah Research Foundation Drug screening and diagnosis based on paracrine tubular renin-angiotensin system
EP2004633A4 (en) * 2006-03-30 2009-08-26 Palatin Technologies Inc LINEAR NATRIURETIC PEPTIDE CONSTRUCTS
CA2647143A1 (en) * 2006-03-30 2007-10-11 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
US8580746B2 (en) * 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
JP5207316B2 (ja) * 2007-05-10 2013-06-12 国立大学法人名古屋大学 腹膜線維化抑制用医薬組成物
US20120208756A1 (en) 2009-07-23 2012-08-16 Igisu Co., Ltd Composition for external preparation for skin
WO2011024973A1 (ja) 2009-08-27 2011-03-03 株式会社 イギス 鼻炎治療剤
MX353295B (es) 2011-01-21 2018-01-08 Endo Kyoko Agente para el tratamiento de la alopecia.
WO2014197806A2 (en) * 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258368A (en) * 1984-04-19 1993-11-02 Scios Nova, Inc. Atrial natriuretic/vasodilator peptide compounds
US4618600A (en) 1984-04-19 1986-10-21 Biotechnology Research Associates, J.V. Novel polypeptide diuretic/vasodilators
US5212286A (en) 1984-04-19 1993-05-18 Scios Nova Inc. Atrial natriuretic/vasodilator peptide compounds
EP0267272A4 (en) 1986-05-09 1990-03-12 Biotechnology Res Associates J ATRIAL NATURAL PEPTIDE RECEPTOR PROTEIN AND ITS DNA CODING.
WO1989000428A1 (en) * 1987-07-17 1989-01-26 Brigham And Women's Hospital Use of atrial peptide antibodies, receptor antagonists, and atrial peptide synthesis inhibitors in controlling renal and systemic vasodilation in diabetes mellitus
US5114923A (en) 1988-05-31 1992-05-19 California Biotechnology Inc. Recombinant techniques for production of novel natriuretic and vasodilator peptides
JP2848411B2 (ja) 1988-08-18 1999-01-20 サイオス インコーポレイテッド 心房性ナトリウム利尿ペプチドクリアランス阻害剤
US5106834A (en) 1988-12-27 1992-04-21 G. D. Searle & Co. Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
EP0914147B1 (en) 2002-10-16
CA2261681A1 (en) 1998-11-26
ID21765A (id) 1999-07-22
CN1226832A (zh) 1999-08-25
JP2000516836A (ja) 2000-12-19
AU733210B2 (en) 2001-05-10
EP0914147A1 (en) 1999-05-12
AU7692698A (en) 1998-12-11
WO1998052599A1 (en) 1998-11-26
BR9804921A (pt) 1999-09-08
US5965533A (en) 1999-10-12
DE69808717D1 (de) 2002-11-21
DE69808717T2 (de) 2003-06-12
KR20000029447A (ko) 2000-05-25

Similar Documents

Publication Publication Date Title
BR0112430A (pt) Composição tópica para cuidado da pele, para cuidado pessoal, e processo para regularizarem a condição da pele e para reduzirem o aparecimento de linhas finas e rugas na pele
CO4830493A1 (es) Anticuerpos contra cd40 humano
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
ES2074042T3 (es) Exotoxina recombinante de pseudomonas construccion de una inmunotoxina activa con efectos secundarios menores.
YU51095A (sh) Benzokazolil - i benzotiazolil-oksazo lidinoni
ES2078521T3 (es) Nuevos conjugados de proteina-polication.
BR0207726A (pt) Sais farmacêuticos
ES2179351T3 (es) Amidas acidas de piridil alqueno y piridil alquino como citoestaticos e inmunosupresores.
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
ES2058151T3 (es) Complejos de saponinas con fosfolipidos y composiciones farmaceuticas y cosmeticas que los contienen.
ES2177323T3 (es) Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
ES2123910T3 (es) Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.
ES2185595T3 (es) Peptidos antivirales modificados y sus composiciones para la prevencion y/o el tratamiento de infecciones viricas.
ES2145836T3 (es) Copolimeros elastomericos termoplasticos injertados de silicona, y composiciones que los contienen para el cuidado del pelo y la piel.
ES2186166T3 (es) Peptido natriuretico atrial (anp) como aditivo para soluciones de dialisis peritoneal.
ES2194935T3 (es) Preparados estables de transglutaminasa y procedimiento para su preparacion.
MX9503529A (es) Derivados de glicinamida, procedimiento para su preparacion y medicamentos que los contienen.
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
BR0311347A (pt) Alcanóis bis-aromáticos
NO973548L (no) Behandling av diabetisk neuropati
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
DK0952853T3 (da) Konjugat omfattende et aktivt middel, et polypeptid og en polyether
AR023699A1 (es) Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica
ES2185671T3 (es) Depsipeptidos ciclicos que contienen acido lactico con 18 atomos en el anillo como agentes endoparasticidas y procedimiento para su obtencion.
EA200501069A1 (ru) Состав для местного применения и способы обработки старческой или повреждённой воздействием окружающей среды кожи